In human aging, lymphocytes display increased sensitivity to tumor necrosis factor-a (TNF-a)-induced apoptosis. TNF-a induces both survival and apoptotic signals. The survival signal is mediated by the activation of NF-jB. Although a role of certain proapoptotic molecules in aging has been reported, a role of altered NF-jB signaling pathway has not been explored in detail. In this study, we have compared TNF-ainduced activation of NF-jB, phosphorylation of IjBa, and the expression of IKKb between lymphocytes from young and aged humans. Furthermore, we have explored a role of IKKb in increased susceptibility of lymphocytes from aged humans to TNF-a-induced apoptosis. Lymphocytes from aged humans displayed decreased activation of NF-jB, reduced phosphorylation of IjBa, and decreased expression of IKKb. In addition, overexpression of IKKb in lymphocytes from aged humans normalized TNF-a-induced apoptosis to the level of young subjects. These data suggest a deficiency of NF-jB signaling pathway and a role of IKKb, at least in part, for increased sensitivity of lymphocytes from aged humans to TNF-a-induced apoptosis.
Introduction
Tumor necrosis factor-a (TNF-a) exerts its biological activity by binding to type 1 and type 2 receptors (TNFR-1 and TNFR-2) and by activating several signaling pathways. [1] [2] [3] [4] [5] [6] [7] [8] TNFRs belong to a large family of nerve growth factor receptors/ TNFRs. [9] [10] [11] These are type I transmembrane receptors with one to five cysteine-rich repeats in their extracellular domains and a common death domain (DD) in their cytoplasmic tail. TNFR-1 contains DD whereas TNFR-2 lacks DD. Therefore, TNFR-1 signals both cell survival and cell death signals; whereas TNFR-2 primarily mediates a cell survival signal. However, recent data suggest that TNFR-2 might potentiate the death signal mediated by TNFR-1. [12] [13] [14] [15] [16] Both cell survival and cell death signals mediated by TNF-a require distinct sets of adapter and other downstream signaling molecules. [1] [2] [3] [4] NF-kB is a heterodimer of p50 and RelA (p65) subunits, which is sequestrated in the cytoplasm by its association with an inhibitory protein IkB. TNF-a induces phosphorylation of IkB at two serine residues, which triggers ubiquitination and subsequent degradation of IkB, resulting in the release and translocation of NF-kB to the nucleus where it binds to kB enhancer elements and induces gene expression, including antiapoptotic genes to provide a survival signal. [17] [18] [19] [20] [21] [22] [23] [24] [25] During human aging, both TNF-a production and TNF-a-induced apoptosis are increased. [26] [27] [28] [29] In this study, we have examined whether decreased NF-kB survival signaling pathway plays a role in increased sensitivity of aged lymphocytes to TNF-ainduced apoptosis. Here, we provide evidence for a role of IKKb (IkB kinase, IKK) in increased sensitivity of aged lymphocytes to TNF-a-induced apoptosis.
Results

TNF-a-induces less activation of NF-jB in T cells from aged humans
Since NF-kB plays an antiapoptotic role [22] [23] [24] [25] and in aging TNF-a-induced apoptosis is increased, [27] [28] [29] we examined whether TNF-a-induced activation of NF-kB was different between lymphocytes from aged and young subjects. Lymphocytes from young and aged subjects were activated with 150 ng/ml of TNF-a for various time intervals and NF-kB.
DNA-binding activity was measured by electrophoretic mobility shift assay (EMSA) and ELISA assays. Figure 1 shows the results of EMSA analysis. The top panel shows a representative gel electrophoresis from one aged and one young subject and the bottom panel shows a quantitative mean of 10 young and 10 aged subjects. A decreased NF-kB activation was observed in aged subjects as compared to young subjects. Figure 2 shows data of ELISA assay for NFkB activity from 10 young and 10 aged subjects. A significantly decreased (Po0.05) NF-kB activation was observed at each point of observation (5 min, 15 min, and 30 min). ELISA assay appears to be more sensitive than EMSA assay as the differences were observed at all points of observation with ELISA assay whereas significant differences between young and aged were observed only at 5 min of stimulation with TNFa when analyzed by EMSA assay.
IjB phosphorylation is decreased in aged lymphocytes
NF-kB is held in the cytoplasm in an inactive state by IkB. [18] [19] [20] [21] The ligation of TNFR with TNF-a results in the phosphorylation of IkB with subsequent ubiquitination and proteasomal degradation, leading to release of NF-kB, which then translocates to the nucleus and binds to its DNA binding sites to activate transcription of a number of genes. [20] [21] [22] Since we observed that NF-kB DNA-binding activity in aging is decreased, we examined if decreased NF-kB activity was due to decreased phosphorylation of IkB. Lymphocytes from young and aged subjects were activated with 150 ng/ml of TNF-a for 2 min, 5 min, and 10 min, protein was extracted and Western blotting was performed with anti-phosphorylated IkB monoclonal antibody (mAb). Actin was used as an internal loading control. The quantitative analysis was performed by densitometry. Figure 3 (top) shows a representative Western blot from one young and one aged subject. A marked decrease in phosphorylated IkB was observed in lymphocytes from aged subjects. Figure 3 (bottom) shows cumulative quantitative data (by densitometry) from 10 young and 10 aged subjects. A significant decreased phosphorylated IkB was observed at both 2 min (Po0.01) and 5 min (Po0.05), following activation of lymphocytes from aged subjects with TNF-a as compared to that in young subjects.
IKKb expression is decreased in aging and increased expression of IKKb in vitro corrects TNF-a-induced apoptosis in aged humans
IKKb is essential for NF-kB activation and inhibition of TNF-ainduced apoptosis. [30] [31] [32] The phosphorylation of IkB is under the control of IKKb, 33, 34 and because IkB phosphorylation is decreased in aging, we examined the expression of IKKb in lymphocytes from aged and young subjects. Lymphocytes from young and aged subjects were activated with anti-CD3, proteins were extracted and expression was determined by Western blotting, using specific mAbs. Figure 4 (top panel) shows a representative experiment; a decreased expression of IKKb was observed in lymphocytes from aged subjects. The bottom panel (Figure 4 ) shows quantitative data from three young and three aged subjects with significantly decreased (Po0.05) expression of IKKb in aging. To determine whether decreased expression of IKKb was responsible for decreased phosphorylation of IkB and reduced NF-kB activity and therefore increased TNF-a-induced apoptosis, lymphocytes from both young and aged subjects were transfected with vector alone or IKKb expression plasmid and then incubated with TNF-a and IKKb expression and activity (phosphorylation Figure 5 ). In addition, IKKb overexpression resulted in increased NF-kB activity ( Figure 6 ). IKKbtranfected lymphocytes in aged subjects showed increased NF-kB activity comparable to the basal NF-kB activity in young subjects. Figure 7 shows that overexpression of IKKb resulted in decreased TNF-a-induced apoptosis in both young and aged subjects, resulting in comparable apoptosis between them.
Overexpression of IKKb inhibits TNF-a-induced apoptosis by upregulating Bcl-2 and cIAP1
To determine the mechanism of IKKb-induced inhibition of apoptosis, cells from aged and young subjects were treated with control plasmid and expression plasmid and examined for Bcl-2, Bcl-x L , Bax, and cIAP1 (Cellular inhibitor of apoptosis protein, CIAP) expression by Western blotting. An overexpression of IKKb resulted in the upregulation of both Bcl-2 and cIAP1 (Figure 8 ). 
Discussion
Aging is associated with progressive decline in immune functions, [35] [36] [37] [38] which is assigned in part to increased apoptosis. [27] [28] [29] [39] [40] [41] [42] [43] [44] [45] [46] [47] During aging there is an increased production of proinflammatory cytokines, including TNF-a. 26 Furthermore, lymphocytes from aged humans are associated with increased susceptibility to TNF-a-induced apoptosis in aged humans, which is associated with increased expression of TNFR-I and decreased expression of TNFR-2. 27 In addition, there appears to be an increased expression and activity of proapoptotic molecules. 27, 41, 48 However, a role of antiapoptotic pathway of apoptosis in TNF-a-induced apoptosis has not been studied in detail.
NF-kB is one of the transcription factors that play an important role in the regulation of immune response genes. [17] [18] [19] [20] NF-kB exists as either heterodimers or homodimers of the subfamily of Rel family of proteins. The predominant form of NF-kB is a heterodimer comprising p50 (NF-kB1) and p65 (RelA). Other forms contain p52 (NF-kB2), RelB, and c-Rel subunits. 18 A number of genes, including cytokines, chemokines, cell surface receptors, and adhesion molecules, are targets of NF-kB. 49 In unstimulated cells, NF-kB is kept in the cytoplasm through interaction with the inhibitory proteins termed as IkB (inhibitor kB). When cells are exposed to inducers of NF-kB, such as TNF, IkB is phosphorylated, which is a signal for ubiquitination and degradation of IkB by the 26S proteasome. Free NF-kB dimmers are released and translocated to the nucleus, where they activate transcription of target genes. In this study, we observed decreased TNF-ainduced NF-kB activation in lymphocytes from aged subjects as determined by ELISA and EMSA assays. Trebilcock and Ponnappan 50 also reported decreased NF-kB activity in aged lymphocytes using EMSA assay. However, Aggarwal et al. 51 observed that diminished response of senescent human fibroblasts to TNF-dependent proliferation and cytokine production was not due to its effect on NF-kB activation.
IkB in response to proinflammatory signals (e.g. TNF-a) is phosphorylated by IKKb. 33, 34 Furthermore, it has been demonstrated that IKKb is essential for the activating of NFkB and protecting cells from apoptosis, including T cells from TNF-a-induced apoptosis. [30] [31] [32] In the present study, lymphocytes from aged humans had decreased expression of IKKb and reduced phosphorylation of IkB. An overexpression of IKKb in aged lymphocytes resulted in normalization of TNF-ainduced apoptosis, thus establishing a role of IKKb in increased apoptosis in lymphocytes from aged humans.
NF-kB has been shown to inhibit apoptosis, especially that triggered by TNF-a. [21] [22] [23] The suppression of apoptosis by NFkB depends on induction of a number of genes whose products regulate apoptosis, including Bcl-2 family 24,52-54 and IAP proteins. 25 cIAPs inhibit apoptosis by direct binding and inhibiting the activation of effector caspase-3 and caspase-7 and preventing activation of procaspase-9. 55 Therefore, decreased NF-kB activity may be associated with decreased Bcl-2/Bcl-X L and/or cIAPs. Previously we have shown decreased Bcl-2 41 and cIAP expression in aged lymphocytes. 56 In the present study, we have demonstrated that overexpression of IKKb resulted in increased IkB phosphorylation, increased NF-kB activity, upregulation of Bcl-2 and cIAP1, and inhibition of TNF-a-induced apoptosis, supporting a role of decreased NF-kB activity in increased sensitivity to TNF-induced apoptosis in lymphocytes from aged humans.
In summary, defects in NF-kB signaling pathway appear to be responsible, at least in part, for increased TNF-a-induced apoptosis in lymphocytes from aged humans.
Materials and Methods
Subjects
A total of 10 healthy young (18 to 30 y) and 10 healthy aged (66 to 88 y) persons, who are living independently and are of upper-middle social class, were the subjects for this study. There were seven female and three Lymphocytes from young and aged subjects were transfected with IKKb expression plasmid or control vector and its effect on TNF-a-induced apoptosis was analyzed by TUNEL assay Figure 8 Effect of transfection with IKKb on Bcl-2 family proteins and cIAP1. To determine the mechanism by which transfection with IKKb resulted in decreased TNF-induced apoptosis, lysates from cells transfected with control and expression plasmid containing 25 mg of total protein were resolved by electrophoresis on 10% SDS-polyacrylamide gels and transferred onto PVDF membranes by electroblotting. The membranes were sequentially probed with the following antibodies: anti-Bcl-2, anti-Bcl-xL, anti-Bax, anti-cIAP, and anti-IkB. Blots were developed with ECL Plus detection system. To verify normalized protein loading and transfer efficiency, the blots were probed with antiactin antibody male subjects in each group. The protocol was approved by the Institution Review Board of the University of California, Irvine. None of them had taken any antioxidants for at least 2 weeks prior to study.
Apoptosis
Apoptosis was measured by TUNEL assay. Cells (1 Â 10 6 /ml) were incubated for 48 h with or without 1 mg/ml of TNF-a. Cells were washed with PBS containing 1% BSA and 0.1% sodium azide and fixed in 2% paraformaldehyde for 30 min at room temperature. Cells were washed with PBS and permeabilized with sodium citrate buffer containing Triton X-100 for 2 min on ice. After washing, cells were incubated with FITC-dUTP in the presence of TdT enzyme solution containing 1 mM potassium cacodylate and 125 mM Tris-Hcl, pH 6.6 (In Situ Death Detection Kit, Boehringer Mannheim, Indianapolis, IN, USA) for 1 h at 371C. Following incubation, cells were washed with PBS and 5000 cells were acquired and analyzed by FACScan.
Transfection of Mononuclear cells with IKKb expression plasmid
Mononuclear cells (MNCs) were activated for 48 h with anti-CD3 mAb and subsequently cultured for 24 h in the medium supplemented with 10 ng/ml of IL-2 and transfected with Ikkb expression plasmid using the Lipofectin reagent (GIBCO BRL, Gaithersberg, MD, USA). The activated MNCs were resuspended at 3 Â 10 6 cells/ml in OPTI-MEM I medium, and 0.8 ml of the cell suspension was placed in each well of six-well plate. For liposome formation, 16 ml of Lipofectin was diluted in 84 ml of OPTI-MEM I medium and 2 mg of plasmid DNA was diluted in 98 ml of OPTI-MEM I medium. The vector plasmid without cloned gene was used as a negative control. After 45 min incubation at room temperature, the DNA and Lipofectin diluents were combined and incubated for 15 min at room temperature. Then, 200 ml of the DNA/Lipofectin mixture was added to each well and cells were incubated for 20 h at 371C. IL-2 supplemented culture medium (3 ml) was added to each well and cells were allowed to express Ikkb for 2 days. Expression of Ikkb was confirmed by real-time RT-PCR.
NF-jB DNA-binding activity
Preparation of nuclear extract
Five million cells were washed with ice-cold PBS and ice-cold buffer A (10 nM HEPES-KOH, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol (DTT), and 0.2 mM phenylmethylsulfonyl fluoride (PMSF)). Cells were resuspended in 400 ml of buffer A, incubated on ice for 15 min, and homogenized by 15 passages through a 25-gauge needle. The nuclei were collected by centrifugation at 600 Â g for 6 min and resuspended in 30 ml of buffer C (20 mM HEPES-KOH, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, and 0.2 mM PMSF). After 15 min incubation on ice, the nuclear extracts were microcentrifuged at 41C for 2 min and the supernatants were collected and stored at À701C until used for the gel mobility shift assay or NF-kB binding ELISA.
Gel mobility shift assay for NF-kB
The assay was performed using 10 mg of protein from each nuclear extract in 20 ml of binding mixture (10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM DTT, 1 mM EDTA, and 5% glycerol) containing 1 mg of poly(dI-dC) and 3 Â 10 5 cpm of 32 P-labeled oligoprobe of NF-kB binding sequence (AGTTGAGGGGACTTTCCCAGG). The specificity of the binding was examined by competitive binding reaction with cold NF-kB oligoprobe before addition of 32 P-labeled oligoprobe. The binding mixture was incubated for 15 min at room temperature and 1 ml of 0.5 M EDTA was added to each reaction to terminate the binding reaction. The probeprotein complex was separated from the probe on a 6% Tris-glycine gel containing 10% glycerol and visualized by autoradiography.
ELISA for NF-kB activity DNA-binding activity of NF-kB was assessed using an ELISA kit for NF-kB p65 according to the manufacturer's protocol (ActivMotif, San Diego, CA, USA). The 96-well plate was coated with the oligonucleotide specific for NF-kB binding and the bound NF-kB was measured using anti-NF-kB p65 antibody. Briefly, 30 ml of binding buffer was added to each well. NFkB binding oligonucleotide or mutated oligonucleotide was added to the binding buffer for negative or positive controls, respectively. Then 20 ml of lysis buffer containing 10 mg of protein from each nuclear extract was added to each well and incubated for 1 h at room temperature with mild shaking. The plate was washed 3 times, treated with anti-NF-kB p65 antibody (1 : 1000 dilution) and incubated for 1 h at room temperature. The plate was washed, treated with HRP-conjugated secondary antibody (1 : 1000 dilution) for 1 h, and washed 4 times before addition of provided developing solution. The reaction was terminated in 5 min by addition of provided stop solution and optical density in each well of the plate was measured at 450 nm using the microtiter plate reader. DNA binding of NFkB in each nuclear extract was presented as OD 450 per milligram nuclear protein. This method provides advantages over EMSA: (1) a sensitive method without using radioactivity, (2) a large number of samples can be analyzed simultaneously.
Western blotting
Cells treated with or without TNF-a (150 ng/ml) for various time intervals were centrifuged and whole-cell extracts were prepared by lysing the cell pellet in 50 ml cold TGNT buffer with protease and phosphatase inhibitors (100 mM Tris-Cl pH 7.4, 20% glycerol, 100 mM NaCl, 2% Triton X-100, 20 mM EGTA, 100 mM NaF, 4 mM phenylmethylsulfonyl fluoride, 4 mM sodium orthovanadate, and 2 mM p-nitrophenol phosphate) and clarified by centrifugation at 41C for 20 min. Protein concentration of the lysates was determined by Bradford assay (Bio-Rad, Richmond, CA, USA). Aliquots of cell lysates containing 25 mg of total protein are resolved by 10% SDSpolyacrylamide gel electrophoresis and transferred onto PVDF membranes by electroblotting. The membranes were blocked for 2 h at room temperature in TBS-T buffer with 5% nonfat dried milk, and sequentially probed by overnight incubation at 41C with antiphospho IkB or IKKb primary antibodies, anti-Bax, anti-Bcl-2, anti-Bcl-xL, anti-cIAP1 diluted in TBS-T buffer with 5% nonfat dried milk (1 : 2000 dilution; Transduction Laboratory, San Diego, CA, USA). The blots were washed 3 times for 15 min with TBS-T buffer and then incubated with HRP-conjugated anti-mouse secondary antibody (1 : 2000 dilution; Cell Signaling Technology, Beverly, MA, USA) for 1 h at room temperature. After washing 3 times for 20 min in TBS-T buffer, blots were developed with ECL Plus detection system (Amersham Pharmacia Biotech Inc, Piscataway, NJ, USA). Before each cycle of reprobing, blots were incubated at 501C for 45 min in stripping buffer (62.5 mM Tris, pH 6.7, 2% SDS, and b-mercaptoethanol). To normalize protein loading and transfer efficiency, the blots were probed with anti-actin antibody (1 : 20 000 dilution).
